Abeona Therapeutics and REGENXBIO Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector
Go back to Abeona Therapeutics and REGENXBIO Announce Worldwide Exclusive Licenses for the Treatment of Four Rare Lysosomal Storage Disorders Using NAV AAV9 Vector| (NASDAQ: ABEO) | Delayed: 5.72 -0.03 (0.52%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.75 | 52 Week High | $9.44 | |||
| Open | $5.68 | 52 Week Low | $2.05 | |||
| Day High | $5.87 | P/E | N/A | |||
| Day Low | $5.67 | EPS | $0.00 | |||
| Volume | 1,015,413 | |||||
